Artal Group S.A. Kura Oncology, Inc. Transaction History

Artal Group S.A.

$214 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $1.75 Million - $2.3 Million	-100,000 Reduced 5.21%	1,819,884 $37.5 Million
Q1 2024 May 13, 2024	BUY	$13.42 - $23.53 $2.04 Million - $3.57 Million	151,828 Added 8.59%	1,919,884 $41 Million
Q4 2023 Feb 09, 2024	SELL	$7.58 - $14.38 $1.9 Million - $3.6 Million	-250,000 Reduced 12.39%	1,768,056 $25.4 Million
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $2.89 Million - $4.2 Million	300,000 Added 17.46%	2,018,056 $21.4 Million
Q1 2023 May 12, 2023	BUY	$10.71 - $14.6 $193,379 - $263,617	18,056 Added 1.06%	1,718,056 $21 Million
Q4 2022 Feb 13, 2023	BUY	$11.23 - $16.9 $6.74 Million - $10.1 Million	600,000 Added 54.55%	1,700,000 $21.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $600,500 - $972,500	50,000 Added 4.76%	1,100,000 $15 Million
Q3 2021 Nov 12, 2021	BUY	$15.42 - $21.72 $6.94 Million - $9.77 Million	450,000 Added 75.0%	1,050,000 $19.7 Million
Q4 2020 Feb 11, 2021	BUY	$29.0 - $41.62 $1.48 Million - $2.12 Million	50,900 Added 9.27%	600,000 $19.6 Million
Q3 2020 Nov 13, 2020	SELL	$16.3 - $30.64 $471,070 - $885,496	-28,900 Reduced 5.0%	549,100 $16.8 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $1.42 Million - $3.35 Million	178,000 Added 44.5%	578,000 $9.42 Million
Q4 2019 Feb 13, 2020	BUY	$12.97 - $15.94 $1.95 Million - $2.39 Million	150,000 Added 60.0%	400,000 $5.5 Million
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $3.69 Million - $5.22 Million	250,000 New	250,000 $3.79 Million
Q2 2018 Aug 10, 2018	SELL	$14.8 - $18.8 $1.48 Million - $1.88 Million	-100,000 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$6.05 - $14.95 $605,000 - $1.5 Million	100,000	100,000 $1.5 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$69 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.8 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$52.3 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.8 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$39 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Account